Big Pharma and intellectual property: Why is India afraid of compulsory licences?
While rich nations are discovering the virtues of compulsory drug licences, India has resolutely turned its back on this tool despite nudges from …
In poll season, Punjab debates legalising poppy seed and opium farming
Proponents feel the two crops will help farmers, save Punjab’s groundwater and wean its youth from synthetic drugs
Vaccines without needles: New shelf-stable film could revolutionise how medicines are distributed worldwide
A research group claims to have developed a method to stabilise live viruses and other biological medicines in a rapidly dissolving film that …
Dark underbelly of Big Pharma lobbying
Recent protests and campaigns in the US have focused on the proposal by India & South Africa at WTO to keep TRIPS in abeyance till the …
AI for drug development: How trustworthy is the tech?
Pharma companies today deploy artificial intelligence with a potential to reduce the drug development cycle by half
Beware of a deal with Trump
As the US president comes visiting to India there is worry about the demands he will make on intellectual property
Software outsmarts drug research
Now, a programme can bypass patented drug pathways and create synthetically-produced medicines
Rise of AMR could result in up to 10 million annual deaths by 2050: UN report
Some 24 million people could be pushed into extreme poverty due to rising AMR, the UNEP said
COVID-19 exposed dependence of world, India on China for active pharma ingredients
APIs are crucial for drugs and countries have put their eggs in a single basket; India has been discussing the issue for sometime
The end of meat and GMOs or the end of us: Part 1
The first in a three-part series series on effects of GMOs and the meat industry on our environment
The world needs pharmaceuticals from China and India to beat COVID-19
Chinese manufacturers make around 40% of all APIs used worldwide; China, India are the source of 75-80% of APIs imported to US
COVID-19 also brings focus back on pollution due to pharmaceuticals
No time for quick-fix measures. India needs stricter laws
AMR driven by manufacturing our next big challenge
Antibiotics production is an important yet often forgotten driver of antimicrobial resistance; an alliance of pioneers has decided to pave the …
National List of Essential Medicines: 34 drugs enlisted in update after 7 years
The latest National List of Essential Medicines features 384 medicines, drops 26 old ones
COVID-19 and the big pharma mess
The pandemic has exposed a serious fault line in the global pharmaceutical supply chain, created by an industry that flourished by putting profit …
Ethical concerns eclipse world’s race to develop Ebola vaccine
World Health Organization and international community have been repeatedly slammed for delayed intervention
Missed calls from patients can help monitor TB treatment, says government
A special treatment kit which eases the procedure of treatment is being tested in two states
Antimicrobial resistance: The need to tackle access-excess problem
AMR, like every process, has its own drivers and determinants. The threat has evolved over time due to our acts of omission and commission
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …
Ebola enters Mali, nearly 10,000 affected globally till now
With this, Mali has become the sixth West African country to be affected in the world's most deadliest outbreak of Ebola
Accident at Sainor unit in Vizag more proof of companies bypassing rules
Life-saving equipments were absent on-site though the company had approvals to show they were present
15 doctors went on foreign jaunt sponsored by pharma company, says Lok Sabha member
Doctors and pharma company deny charges
COVID-19: Centre brings package to boost bulk drugs
Indian pharma industry is critically dependent on imported raw material
Marxists vs Paternalists vs Liberals: Where healthcare stands in India
How health as a right, investment and consumption regularly crops up in capitalist discourses
Phase-II trials for new clot buster drug approved
Bio-therapeutic drug, Clot Specific Streptokinase, meant for patients who suffer heat attack, was developed using bacteria